{
  "meta": {
    "timestamp": "2025-01-06T10:46:16.460179",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Enfusion Inc.",
      "symbol": "ENFN",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Intense competition from established players and emerging FinTech startups",
            "Evolving regulatory requirements across multiple jurisdictions",
            "Client concentration risks with significant revenue tied to a limited number of large clients",
            "Ongoing risks of data breaches and cyberattacks",
            "High dependency on recurring subscription-based revenue"
          ],
          "controversies": [
            "Earnings miss in Q2 2024 leading to stock price decline",
            "Insider selling activity raising investor concerns",
            "Legal investigations by multiple law firms following earnings miss and stock price decline"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Cybersecurity threats undermining client trust and leading to financial losses",
            "High dependency on subscription-based revenue posing risks if client retention or market demand declines"
          ],
          "governance_issues": [
            "Regulatory compliance challenges and the need to improve T+1 settlement processes",
            "Insider selling activity raising governance concerns"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Governance Documents - Enfusion",
              "snippet": "You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Enfusion to send you the requested Investor Email Alert updates.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128468+00:00",
              "published_date": null,
              "source_hash": "242d1af8b53077b9e3a3c636c8802f0d"
            },
            {
              "url": "",
              "title": "What Happens When the Cloud Comes to a Highly Regulated Industry?",
              "snippet": "Blake Nielsen is the General Counsel and Vice President of Operations at Enfusion, a technology consulting business for asset management companies and the provider of cloud-based, multi-tenant investment management system Integr\u00e1ta.In this interview, Blake discusses what to expect and the legal challenges of a company that is filling a technological gap in a highly regulated indutry.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128580+00:00",
              "published_date": null,
              "source_hash": "f1ada47a857b8416e1539444caa5b3b8"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "ENFUSION, INC. FQ2 2024 EARNINGS CALL AUG 06, 2024 ... Enfusion improves the transition process to T+1 settlement and automate regulatory compliance oversight. We have stated throughout the year, we have been pushing hard to win more ... trade compliance, systematic APIs as well as newly released cash letter reporting. This is a very exciting",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128603+00:00",
              "published_date": null,
              "source_hash": "019ac6d6d019fff5dccdc4959b07f53d"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 - Fintel",
              "snippet": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 ... eliminating complicated upgrade and version control issues and providing the agility to meet rapidly evolving industry needs; ... ability to support regulatory requirements and compliance. We believe that we compete favorably with respect to these factors. However, many of our ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128617+00:00",
              "published_date": null,
              "source_hash": "672a0be1dd7bb0c21ef2ad0c75e2e933"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Enfusion, Inc. (\"Enfusion\" or the \"Company\") has filed a registration statement (including a preliminary prospectus) on Form S-1 (File No. 333-259635) with the Securities and Exchange Commission (the \"SEC\") for the offering to which this presentation ... customers; overall economic conditions; and our compliance with extensive laws and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128632+00:00",
              "published_date": null,
              "source_hash": "1d0276be2ae19b5bd48913480a285c8d"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "The Board of Directors of Enfusion, Inc. (together with its subsidiaries, the \"Company\") has ... rule or regulation, to the appropriate regulatory authority. Employees, officers and directors shall not discharge, demote, suspend, threaten, harass or in any other ... Compliance Officer, who may notify the Board or a committee of the Board as ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128645+00:00",
              "published_date": null,
              "source_hash": "16b6dbf30111e9277db8b2b8e518218f"
            },
            {
              "url": "",
              "title": "ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud ...",
              "snippet": "Enfusion reported its financial results for the second quarter of 2024 on August 6, 2024. The Company missed consensus estimates for both earnings and revenue. The Company missed consensus ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128657+00:00",
              "published_date": null,
              "source_hash": "b43e0460445657bd4b6767086f93dd4b"
            },
            {
              "url": "",
              "title": "Enfusion Inc Is Being Investigated For Violating Securities Laws And ...",
              "snippet": "Based on this news, shares of Enfusion fell by 7.86% on the same day. If you are a shareholder who suffered a loss, click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172520+00:00",
              "published_date": null,
              "source_hash": "a70d74da9b1fecb8f3866bc81efe6dfa"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. 10K Annual Reports & 10Q SEC Filings - Last10K.com",
              "snippet": "Assess how Enfusion, Inc.'s management team is paid from their Annual Proxy. Screenshot example of actual Proxy Statement. Enfusion, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes: Voting Procedures; Board Members; Executive Team; Salaries, Bonuses, Perks;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128681+00:00",
              "published_date": null,
              "source_hash": "50a185de0e6337a23bbf00d6805178bd"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. ESG Risk Rating - Sustainalytics",
              "snippet": "Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:42.128693+00:00",
              "published_date": null,
              "source_hash": "390beba4167d09b7287ae2e76e03158f"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave Higher",
              "snippet": "To address these issues, financial institutions ... seamless communication and compliance among portfolio managers, traders, and compliance teams. Enfusion, Inc. (NYSE:ENFN) reported a revenue ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:44.684878+00:00",
              "published_date": "2024-10-18T08:11:00+00:00",
              "source_hash": "204dd6790e57ca71d5dccf5d2f0bd3d9"
            },
            {
              "url": "",
              "title": "Enfusion price target raised to $11.50 from $10 at Piper Sandler",
              "snippet": "Piper Sandler raised the firm's price target on Enfusion (ENFN ... initial public offerings and a lighter regulatory environment. This has led to an increase in stock prices and multiples ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:44.684962+00:00",
              "published_date": "2024-12-23T10:15:00+00:00",
              "source_hash": "cf90108945cb12f65f248a94573b81b4"
            },
            {
              "url": "",
              "title": "Enfusion (NYSE:ENFN) Shares Gap Down Following Insider Selling",
              "snippet": "Enfusion, Inc. (NYSE:ENFN - Get Free Report)'s stock price gapped down prior to trading on Friday after an insider sold shares in the company. The stock had previously closed at $10.69, but opened at $10.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:56.749973+00:00",
              "published_date": "2024-12-28T05:10:00+00:00",
              "source_hash": "89623693f5eab59cda6188b29e94935f"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring Sells 24,443 Shares of Stock",
              "snippet": "CFO Bradley Herring sold 24,443 shares of the firm's stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $10.61, for a total value of $259,340.23. Following the transaction,",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T17:45:44.684988+00:00",
              "published_date": "2024-12-27T08:50:00+00:00",
              "source_hash": "b214c84783057fa5371a9ae857184041"
            },
            {
              "url": "",
              "title": "Enfusion To Present at Upcoming Investor Events",
              "snippet": "NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. (\"Enfusion\") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:50.955537+00:00",
              "published_date": "2024-11-20T16:15:00+00:00",
              "source_hash": "d6f696b8c99f9a0e9434ab7aebbfa9ac"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC ...",
              "snippet": "On August 6, 2024, Enfusion reported its financial results for the second quarter of 2024. The Company missed consensus estimates for both earnings and revenue. Following this news, Enfusion stock ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172207+00:00",
              "published_date": null,
              "source_hash": "6ea9aa2b6d8ea7c1b5f6e4ba2c08a55f"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of ...",
              "snippet": "NEW YORK, March 19, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (\"Enfusion\" or the \"Company\") (NYSE: ENFN).Such investors are advised to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172339+00:00",
              "published_date": null,
              "source_hash": "14847f0513787963ed10eb0ab660028d"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims - GlobeNewswire",
              "snippet": "NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (\"Enfusion\" or the...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172372+00:00",
              "published_date": null,
              "source_hash": "69c8a413bf79139deb42ff087b181ae4"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "Then, on August 6, 2024, Enfusion issued a press release reporting its financial results for the second quarter of 2024. Among other items, Enfusion reported non-GAAP earnings per share of $0.05, missing consensus estimates by $0.01, as well as revenue of $49.5 million, missing consensus estimates by approximately $475,000.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172399+00:00",
              "published_date": null,
              "source_hash": "d932d42332e0312ccde0eed3dd081d29"
            },
            {
              "url": "",
              "title": "Pomerantz Law Firm Investigates Claims on Behalf of Investors of ...",
              "snippet": "NEW YORK, April 12, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (\"Enfusion\" or the \"Company\") (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172424+00:00",
              "published_date": null,
              "source_hash": "37c79c57aef17a442c674524cd68ce8a"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (\"Enfusion\" or the \"Company\") (NYSE:ENFN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.. The investigation concerns whether Enfusion and certain of its officers and/or directors have engaged in securities ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172448+00:00",
              "published_date": null,
              "source_hash": "27d2a18b639a5de89e378144b4a6111b"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 - Fintel",
              "snippet": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 ... Breaches of our security systems, including unauthorized or improper employee access to client portfolios or other material non-public information, could expose us to losses. We maintain a system of controls over the physical security of our facilities. We also manage and store various ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172473+00:00",
              "published_date": null,
              "source_hash": "b940f2161602a898daeee8d98a81a400"
            },
            {
              "url": "",
              "title": "Enfusion Cyber Security Rating & Vendor Risk Report | SecurityScorecard",
              "snippet": "Enfusion is a company that provides software-as-a-service (SaaS) for the investment management industry. It develops a platform for accounting, portfolio management, trading, operations, analytics, compliance and risk, and system administration management.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172497+00:00",
              "published_date": null,
              "source_hash": "2ff3130fca24855cdda446edcc59be91"
            },
            {
              "url": "",
              "title": "Enfusion Inc | Reuters",
              "snippet": "The latest international Enfusion Inc news and views from Reuters - one of the world's largest news agencies",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:48.172543+00:00",
              "published_date": null,
              "source_hash": "095c9197970541ec14b9327db9bf8246"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave Higher",
              "snippet": "In this article, we are going to take a look at where Enfusion, Inc. (NYSE:ENFN ... AI's influence is also reshaping the cybersecurity landscape for fintechs. While AI strengthens defenses ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:50.955344+00:00",
              "published_date": "2024-10-18T08:11:00+00:00",
              "source_hash": "5e6458a906f8600a9516aef18b52ac3a"
            },
            {
              "url": "",
              "title": "Sell Alert: Bradley Herring Cashes Out $259K In Enfusion Stock",
              "snippet": "All You Need to Know About Enfusion Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:50.955473+00:00",
              "published_date": "2024-12-27T15:02:00+00:00",
              "source_hash": "7e31a479b10c873ee2c626c57ee1dff3"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN)",
              "snippet": "NEW YORK & LONDON & HONG KONG, November 20, 2024--Enfusion, Inc. (\"Enfusion\") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:50.955512+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "2c342eaedf97ef3ff0c113045c7605e0"
            },
            {
              "url": "",
              "title": "Enfusion (NYSE:ENFN) Stock Quotes, Forecast and News Summary",
              "snippet": "Taking a Look at Key Metrics Versus Estimates Enfusion, Inc. (NYSE: ENFN) reported $49.46 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 15.8%.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Enfusion Inc. Enfusion Inc. cybersecurity breaches",
              "retrieved_at": "2025-01-06T17:45:50.955561+00:00",
              "published_date": "2024-12-18T08:35:00+00:00",
              "source_hash": "02744e520961b1a7b524d9c681bdc4e3"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. SEC 10-Q Report \u2014 TradingView News",
              "snippet": "Challenges and Risks. Enfusion, Inc. faces several challenges and risks in the current market environment: Market Risks: Revenue Concentration: Enfusion's total revenues were 99.4% recurring subscription-based during the three and nine months ended September 30, 2024. This high dependency on subscription-based revenue could pose a risk if there ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.319914+00:00",
              "published_date": null,
              "source_hash": "7ce9ffb247e290ab7384ae6f999d1c33"
            },
            {
              "url": "",
              "title": "Enfusion Inc: Business Model, SWOT Analysis, and Competitors 2024",
              "snippet": "Cybersecurity Risks: As a cloud-based platform, Enfusion is susceptible to cybersecurity threats, which could undermine client trust and lead to financial losses. Regulatory Risks: Changes in regulations could impose additional compliance burdens on Enfusion and its clients, potentially impacting its business model. Competitors of Enfusion Inc.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320035+00:00",
              "published_date": null,
              "source_hash": "bf6822e6d0ae3ea3d2bdf03932893c4d"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "ENFUSION, INC. (Exact name of registrant as specified in its charter) Delaware 87-1268462 ... Risk Factors 12 Item 1B. Unresolved Staff Comments 40 Item 1C. Cybersecurity 40 Item 2. Properties 41 Item 3. Legal Proceedings 42 Item 4. Mine Safety Disclosures 42 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320056+00:00",
              "published_date": null,
              "source_hash": "1155eceb3ac5935fe0d310246641d38a"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "ENFUSION, INC. FQ3 2024 EARNINGS CALL NOV 04, 2024 ... numerous risks and uncertainties, including those set forth in our filings with the SEC, which are available in the Investor Relations section of our website. Actual results may differ materially from any forward-looking statements we make today. ... This brings our total client count to ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320072+00:00",
              "published_date": null,
              "source_hash": "140011124b34e1dd072c4e25130d1eb1"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Enfusion started the year with excellent results, positioning us to execute on our 2024 targets. We also hosted our first Investor Day this Quarter, on March 19 th , in Ft Lauderdale, where we detailed the pieces now in place for Enfusion to achieve our 2024 targets, as well as our objective to achieve 20% plus revenue growth over the medium ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320085+00:00",
              "published_date": null,
              "source_hash": "c3cb0a31888460f47da7bced6bf25862"
            },
            {
              "url": "",
              "title": "Enfusion Inc. - Spruce Point Capital Management LLC",
              "snippet": "Spruce Point Capital warns of a 40-60% downside risk for Enfusion (ENFN), citing high financial restatement risk, executive turnover, and revenue misstatement concerns. Home About Us Research Newsroom Careers Contact. ... Enfusion Inc. Download Report 7. Research Overview. INDEX: S&P 500. Sector: Technology. Position: Short. Date: Mar 14, 2024 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320097+00:00",
              "published_date": null,
              "source_hash": "37d8012c123d2713f9ed6e7449543b5c"
            },
            {
              "url": "",
              "title": "Breaking Down Enfusion, Inc. (ENFN) Financial Health: Key Insights for ...",
              "snippet": "A Deep Dive into Enfusion, Inc. (ENFN) Profitability A Deep Dive into Enfusion, Inc.'s Profitability. Gross Profit: For the nine months ended September 30, 2024, the gross profit amounted to $100.2 million, which represents an increase of $14.2 million or 16.5% compared to $86.0 million for the same period in 2023 .. Gross Profit Margin:",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320111+00:00",
              "published_date": null,
              "source_hash": "8fd3d923552ae8c7675147540dfdf3dc"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 - Fintel",
              "snippet": "Enfusion, Inc. - 10K - Annual Report - March 30, 2022 ... Our Clients and Client Service. Enfusion has a diverse, global client base of 734 clients as of December 31, 2021, ranging from alternative investment managers such as hedge funds of all types, family offices and corporate investment arms, to institutional investment managers such as ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320124+00:00",
              "published_date": null,
              "source_hash": "5a5d409181953c33cd8620a58fa7bfc5"
            },
            {
              "url": "",
              "title": "Enfusion Inc, ENFN:NYQ profile - FT.com - Financial Times",
              "snippet": "Its solution is highly configurable to different work streams, client segments and asset classes. The Company's solution includes portfolio management system, order and execution management system, accounting/general ledger system, Enfusion Analytics System and technology-powered, managed services. ... Year on year Enfusion Inc grew revenues 16 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320136+00:00",
              "published_date": null,
              "source_hash": "28df94cdd1323379d4a377ce437a0836"
            },
            {
              "url": "",
              "title": "Enfusion Investment Management Platform",
              "snippet": "Enfusion simplifies investment management by uniting front-, middle- and back-office functions under a single SaaS-native platform. ... Portfolio managers, risk, and accounting continuously see exactly what the trading desks see, from market open to close. Work from anywhere. ... Insights from Enfusion's Client Forum Learn More. Asset Managers /",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:54.320149+00:00",
              "published_date": null,
              "source_hash": "08edcdbbead324fe769e2bc91faaae76"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN): This Fintech Stock Is Riding the AI Wave Higher",
              "snippet": "The deployment of specialized hardware further underscores the commitment to refining processes, managing risk ... Enfusion, Inc. (NYSE:ENFN) highlighted its ongoing investment in client services ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:56.749798+00:00",
              "published_date": "2024-10-18T08:11:00+00:00",
              "source_hash": "aca8015864fcc02e950ce63c153f997a"
            },
            {
              "url": "",
              "title": "Enfusion (NYSE:ENFN) Shares Down 1.9% - Time to Sell?",
              "snippet": "Enfusion, Inc. (NYSE:ENFN - Get Free Report)'s stock price fell 1.9% during trading on Tuesday . The stock traded as low as $10.12 and last traded at $10.27. 31,225 shares changed hands during trading,",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:56.749901+00:00",
              "published_date": "2024-12-31T16:36:00+00:00",
              "source_hash": "93d886b27773c29f2b34a399c98dd1d8"
            },
            {
              "url": "",
              "title": "Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last?",
              "snippet": "Enfusion, Inc. ENFN shares rallied 5% in the last trading ... Enfusion is benefiting from robust client acquisition and successful expansion into institutional asset management markets.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:56.749929+00:00",
              "published_date": "2024-09-23T17:14:00+00:00",
              "source_hash": "b2fc27d120d45c5ca9aa8cbcddbfe7b4"
            },
            {
              "url": "",
              "title": "Enfusion, Inc. (ENFN)",
              "snippet": "As 2025 begins, U.S. stock markets are showing signs of recovery following a challenging end to 2024, with major indices like the Dow Jones Industrial Average and S&P 500 poised for gains.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Enfusion Inc. Enfusion Inc. client concentration risks",
              "retrieved_at": "2025-01-06T17:45:56.749952+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "32ad3bb44fe0098c983881ae557ec2c8"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Enfusion Inc. regulatory compliance issues",
              "rationale": "Investigate potential legal and regulatory challenges in multiple jurisdictions",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Enfusion Inc. cybersecurity breaches",
              "rationale": "Assess risks related to data security and cyberattacks given the sensitive nature of financial data",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Enfusion Inc. client concentration risks",
              "rationale": "Examine potential vulnerabilities due to reliance on a limited number of large clients",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T10:46:16.460190",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}